ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682298 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682298; 2) Community: the network communities that were significantly associated with the response to NSC 682298; 3) Molecule: the relationships between components within communities and NSC 682298; 4) MDR: the compounds that were significantly associated with the NSC 682298.

NSC Compound Enrichment Correlation
NSC 659948 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.000871592241209852 0.74291736
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.000871592241209852 0.8093507
NSC 103704 Null 0.000880521445136051 0.60968337
NSC 185049 Hydrazinecarbothioamide, 2-[[5-(1-oxopropoxy)-2-pyridinyl]methylene]- 0.000880521445136051 0.64158156
NSC 320846 Batracylin, Daniquidone 0.000880521445136051 0.56841586
NSC 683555 Camptothecin Derivative 0.000880521445136057 0.85805257
NSC 100880 Camptothecin 0.00094423800811012 0.84579841
NSC 672974 Null 0.00094423800811012 0.7189548
NSC 681641 Camptothecin Derivative 0.00094423800811012 0.73732355
NSC 701743 Null 0.000944238008110127 0.81591877
Total:52  Current:2    [First] [Prev] [Next] [Last]